๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
Efficacy and Safety of ZSP1273 in Children 12-17 Years Old With Influenza A
NCT07229820Influenza A
Guangdong Raynovent Biotech Co., Ltd
Phase 3
157
Shanghai
2025-11-08
Recruiting
A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases
NCT07333118Moderate to Severe Refractory Autoimmune Disease
Grit Biotechnology
Phase EARLY_PHASE1
22
Shanghai
2025-11-07
Recruiting
A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors
NCT07265921Advanced Solid Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
232
Beijing, Nanjing, Shanghai, Tianjin, Wuhan
2025-11-07
Active, closed
A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19
NCT07269587ALL (Acute B-Lymphoblastic Leukemia), CAR-T Cell Therapy
Ruijin Hospital
Observational
275
Shanghai
2025-11-07
Recruiting
Effect of Delayed Remote Ischemic Preconditioning on Postoperative Pulmonary Complications in Elderly Patients Having Non-Cardiac Thoracic Surgery
NCT07208500Pulmonary Complications in Surgical Patients
Shanghai Geriatric Medical Center
Not applicable
390
Shanghai
2025-11-06
Not yet open
Evaluation of the Efficacy and Safety of Magnetically-controlled Capsule Gastroscopy for Postoperative Assessment in Elderly Patients and Patients With Underlying Diseases
NCT06029608Evaluation,Efficacy,Safety
Shanghai Jiao Tong University School of Medicine
Observational
120
Shanghai
2025-11-06
Recruiting
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
NCT07170917Hidradenitis Suppurativa
DrugBrivekimig
Sanofi
Phase 2
208
Chengdu, Guangzhou, Shanghai, รœrรผmqi
2025-11-06
Recruiting
Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
NCT07052383Osteosarcoma, Soft Tissue Sarcoma
Tcelltech Inc.
Phase 1
15
Shanghai
2025-11-06
Recruiting
Suture-Mediated Closure System Following Percutaneous Common Femoral Vein Procedures
NCT07554976Percutaneous Intervention Via Common Femoral Vein
Suzhou Hengruihongyuan Medical Technology Co. LTD
Not applicable
136
Shanghai
2025-11-05
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of SV001 in Patients With Idiopathic Pulmonary Fibrosis
NCT07121413Idiopathic Pulmonary Fibrosis(IPF)
DrugSV001
Shanghai Synvida Biotechnology Co.,Ltd.
Phase 2
48
Chengdu, Guangzhou, Hangzhou, Nanchang, Nanjing, Neimeng, Shanghai, Tianjin
2025-11-04
Recruiting
AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)
NCT07544784Colorectal Cancer Liver Metastases (CRLM)
Fudan University
Phase 2
73
Shanghai
2025-11-04
Recruiting
The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status
NCT07383974Healthy Volunteers, Dietary Supplementation, Skin Health, Health Status
ChinaNorm
Not applicable
120
Shanghai
2025-11-03
Recruiting
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo
NCT07108283Nonsegmental Vitiligo
DrugZasocitinib
Takeda
Phase 2
200
Wuhan, Xi'an, Shanghai, Kunming, Hangzhou
2025-11-03
Recruiting
CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
NCT06994975Acute Ischemic Stroke
Huashan Hospital
Phase 3
890
Shanghai
2025-11-03
Recruiting
Multi-Omics-Based Prediction of Allograft Dysfunction After Lung Transplantation
NCT07243964Lung Diseases
Chang Chen
Observational
244
Shanghai
2025-11-01
Recruiting
Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
NCT07157631Liver Transplantation, Tranexamic Acid, End-stage Liver Disease (ESLD)
DrugTranexamic Acid
RenJi Hospital
Not applicable
1,546
Shanghai
2025-11-01
Recruiting
The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion Therapy
NCT07757165Advanced Metastatic Gastric Cancer
Fudan University
Phase 2
126
Shanghai
2025-11-01
Recruiting
A IIT Study of 177Lu-DOTA-SNA040
NCT07595237Advanced Solid Tumors (Such as Gastric Cancer), Advanced Solid Tumors (Such as Adenocarcinoma at the Gastroesophageal Junction), Advanced Solid Tumors (Such as Pancreatic Cancer), Advanced Solid Tumors (Such as Cholangiocarcinoma)
SmartNuclide Biopharma
Phase EARLY_PHASE1
12
Shanghai
2025-11-01
Not yet open
Pulsed Field Ablation of SVC and PV in Paroxysmal Atrial Fibrillation (PASPA Study)
NCT07191626Paroxysmal Atrial Fibrillation, Paroxysmal Atrial Fibrillation (PAF)
Changhai Hospital
Not applicable
650
Shanghai
2025-11-01
Recruiting
Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery
NCT07264556Colorectal Cancer, Opioid-free Anesthesia, NETs
Fudan University
Not applicable
90
Shanghai
2025-11-01
Recruiting
Biomarkers for Left Ventricular Reverse Remodeling in Heart Failure (REVERT-HF)
NCT07701876Heart Failure, Heart Failure and Reduced Ejection Fraction
Ruijin Hospital Luwan Branch
Observational
1,740
Shanghai
2025-11-01
By invitation
Efficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's Disease
NCT07543094Alzheimer Disease
Ruijin Hospital
Not applicable
40
Shanghai
2025-11-01
Recruiting
Phase I/II Clinical Study of GT201 Injection as Monotherapy or in Combination With PD-1 Inhibitor for Advanced Solid Tumors
NCT06144671Advanced Solid Tumors
DrugsGT201·Interleukin-2
Grit Biotechnology
Phase 1/2
78
Shanghai, Chengdu
2025-11-01
Not yet open
Effectiveness of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction in Pediatric Tethered Cord Syndrome Post-Surgery
NCT07062133Postoperative Neurogenic Lower Urinary Tract Dysfunction Secondary to Tethered Cord Syndrome
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Not applicable
50
Shanghai
2025-11-01
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
NCT07223593Peripheral Arterial Disease
DrugOrforglipron
Eli Lilly and Company
Phase 3
1,205
Beijing, Chengdu, Guangzhou, Harbin, Luoyang Shi, Nanjing, Shanghai, Tianjin
2025-10-31
Recruiting
A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
NCT07494409Anemia Due to Chronic Kidney Disease
DrugsESA·AND017
Kind Pharmaceuticals LLC
Phase 3
300
Shanghai
2025-10-31
By invitation
A Single-Arm Study on the Efficacy of Sequential Chemoradiotherapy Followed by Surgery in Adult Nasal and Paranasal Sinus Rhabdomyosarcoma
NCT07449949ORR, PFS, OS
Eye & ENT Hospital of Fudan University
Observational
43
Shanghai
2025-10-30
Not yet open
A Prospective๏ผŒSingle Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy
NCT06730932Unresectable or Advanced Clear Cell Renal Cell Carcinoma That Has Progressed After Previous Immunotherapy
RenJi Hospital
Phase 2
31
Shanghai
2025-10-30
Recruiting
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
NCT07219615Chronic Spontaneous Urticaria
DrugRitlecitinib
Pfizer
Phase 2
200
Beijing, Guangzhou, Shijiazhuang, Shanghai, Tianjin, Hangzhou
2025-10-30
Recruiting
F182112 Phase Ib Clinical Study for the Treatment of Patients With Systemic Lupus Erythematosus
NCT07829614Systemic Lupus Erythematosus (SLE)
DrugF182112
Shandong New Time Pharmaceutical Co., LTD
Phase 1
64
Shanghai
2025-10-30
By invitation
Comparison of Accuracy of Full-arch Implant Digital and Conventional Impressions.
NCT07190820Edentulous Jaw
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
24
Shanghai
2025-10-30
Recruiting
Impact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control Study
NCT07236541Lung Fibrosis
Ming Zhong
Observational
20
Shanghai
2025-10-30
Recruiting
A Study of Ivonescimab in First-Line ES-SCLC
NCT07245446Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Akeso
Phase 2
180
Beijing, Xi'an, Shanghai
2025-10-29
Recruiting
Population Pharmacokinetics and Pharmacodynamics of Ciprofol
NCT07301242Hip Fractures (ICD-10 72.01-72.2), Osteoarthritis, Knee and Hip, Femoral Neck Fractures
Shanghai Geriatric Medical Center
Observational
50
Shanghai
2025-10-28
By invitation
To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects
NCT07371065Major Depressive Disorder
Luye Pharma Group Ltd.
Phase 1
98
Shanghai
2025-10-28
Recruiting
A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors
NCT07256782Advanced Solid Tumor
DrugsQL2107·QLC5508·Cisplatin/carboplatin·Iparomlimab and Tuvonralimab
Qilu Pharmaceutical Co., Ltd.
Phase 1/2
444
Shanghai
2025-10-24
Recruiting
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer๏ผˆNSCLC๏ผ‰ Patients
NCT07171606First-line Advanced NSCLC Patients
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2
240
Shanghai
2025-10-24
Recruiting
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
NCT07091305Limited-stage Small Cell Lung Cancer (LS-SCLC), Chemoradiotherapy, Induction Therapy, Consolidation Immunotherapy
DrugIparomlimab and Tuvonralimab
Shanghai Chest Hospital
Phase 2
28
Shanghai
2025-10-23
Active, closed
A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer
NCT07196774Early-stage or Locally Advanced HER2-positive Breast Cancer
DrugsPertuzumab·Trastuzumab Rezetecan·Trastuzumab·Carboplatin
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
740
Shenyang, Shanghai
2025-10-23
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
NCT07219173Asthma
DrugBrenipatide
Eli Lilly and Company
Phase 2
531
Baotou, Beijing, Chengdu, Chongqing, Hangzhou, Nanchang, Nanjing, Shanghai
2025-10-22
Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
NCT07213791Ovarian Neoplasms, Breast Neoplasms, Pancreatic Intraductal Neoplasms, Colorectal Neoplasms
Eli Lilly and Company
Phase 1
241
Shanghai
2025-10-22
Recruiting
A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
NCT07234591Plaque Psoriasis, Moderate to Severe Plaque Psoriasis
Usynova Pharmaceuticals Ltd.
Not applicable
140
Shanghai
2025-10-21
Not yet open
Multi-omics Study of Peritoneal Dialysis Effluent to Explore Biomarkers of Peritoneal Fibrosis
NCT07208513Peritoneal Dialysis, Peritoneal Fibrosis
Shanghai Jiao Tong University School of Medicine
Observational
55
Shanghai
2025-10-20
Recruiting
Evaluation of the Clinical Outcomes of the Embolic Protection System in Preventing Distal Embolism During Femoropopliteal Debulking Procedures
NCT07282301Femoropopliteal Disease
RenJi Hospital
Observational
150
Shanghai
2025-10-20
By invitation
A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia
NCT07521683Schizophrenia(Acute)
NeuShen Therapeutics
Phase 2
150
Shanghai
2025-10-20
Recruiting
Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease
NCT07157345Parkinson Disease (PD)
DrugPDR001
Ruijin Hospital
Phase 1
12
Shanghai
2025-10-20
Recruiting
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
NCT07285850HCC - Hepatocellular Carcinoma
DrugAtezolizumab
Eastern Hepatobiliary Surgery Hospital
Phase 2/3
20
Shanghai
2025-10-20
Active, closed
Multicenter Study to Develop a Model to Identify Uric Acid Urinary Tract Stones Using CT and Lab Tests
NCT07328932Urinary Tract Stones
Jian Zhuo
Observational
1,650
Shanghai
2025-10-20
Recruiting
A Study to Evaluate Safety and Efficacy of WSD0922-FU Combo With Osimertinib for NSCLC
NCT07206498Non Small Cell Lung Cancer (NSCLC)
DrugsWSD0922-FU·Tagrisso·Osimertinib
Wayshine Biopharm, Inc.
Phase 1/2
48
Shanghai
2025-10-17
Recruiting
A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer
NCT07168200Advanced Cervical Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd
Phase 3
720
Shanghai
2025-10-17
Recruiting
Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression
NCT05465252Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
24
Shanghai
2025-10-17
Recruiting
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
NCT07209761Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
532
Beijing, Fuzhou, Shenzhen, Wuhan, Nanjing, Jinan, Shanghai, Chengdu
2025-10-16
Active, closed
Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer
NCT07262671NSCLC (Advanced Non-small Cell Lung Cancer)
Fudan University
Observational
100
Shanghai
2025-10-16
Recruiting
Construction of a Portal Hypertension Biobank
NCT07419724Variceal Bleeding, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,000
Shanghai
2025-10-16
Not yet open
A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors
NCT07170787Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2
104
Shanghai
2025-10-15
Recruiting
The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors
NCT07159048Hepatocellular Carcinoma, Colorectal Cancer Liver Metastasis
Fudan University
Not applicable
120
Shanghai
2025-10-15
Not yet open
Iparomlimab and Tuvonralimab Combined With GC in Advanced ICC
NCT07152769Advanced Intrahepatic Cholangiocarcinoma
DrugsGC·Iparomlimab and Tuvonralimab·Sintilimab
Fudan University
Phase 2
104
Shanghai
2025-10-15
Recruiting
Clinical Study of 177Lu-CTR-FAPI In the Treatment of Patients With Advanced, Metastatic Solid Tumors
NCT07229768Pancreatic Cancer
Yan Xing
Phase EARLY_PHASE1
4
Shanghai
2025-10-15
Recruiting
Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis
NCT07721142Rheumatoid Arthritis (RA)
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Phase 4
300
Shanghai
2025-10-15
Recruiting
The Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
NCT07369830Rectal Cancer
DrugClostridium butyricum , Live
Huashan Hospital
Not applicable
156
Shanghai
2025-10-15
Recruiting
Efficacy and Safety of HDM1005 in Chinese Obesity or Overweight Patients Without Diabetes
NCT07279194Obesity & Overweight
DrugsHDM1005 1·HDM1005 2
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
825
Shanghai
2025-10-14
Recruiting
To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
NCT07303465KRAS G12D Mutations, Pancreatic Ductal Adenocarcinoma (PDAC)
DrugRNK08954
Ranok Therapeutics (Hangzhou) Co., Ltd.
Phase 2
60
Nanjing, Shanghai
2025-10-14
Recruiting
Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy
NCT07202559Pancreatitis, Chronic, Pancreatitis, Acute, Pancreatic Duct Stones
Changhai Hospital
Not applicable
1,250
Baotou, Beijing, Hangzhou, Hunan, Lanzhou, Shandong, Shanghai, Yunnan
2025-10-13
Recruiting
Effectiveness of High-Energy Density Enteral Nutrition for Enhancing Physical Growth and Cognitive Brain Development in Infants With Congenital Heart Disease
NCT07115108Congenital Heart Disease, Enteral Nutrition, Pediatrics
Children's Hospital of Fudan University
Not applicable
160
Shanghai
2025-10-13
Recruiting
A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
NCT07129343Von Willebrand Disease (VWD)
DrugAdvate
Takeda
Phase 3
20
Beijing, Guangzhou, Jihan, Shanghai, Suzhou, Tianjin, Wuhan
2025-10-13
Active, closed
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Barrier Repair
NCT07645339Impaired Barrier
L'Oreal
Not applicable
35
Shanghai
2025-10-13
Active, closed
Efficacy and Safety of a Topical Botanical Extract Formulation for Skin Aging
NCT07780799Aging, Dry Skin
L'Oreal
Not applicable
66
Shanghai
2025-10-11
Recruiting
The Fever Clinic Acute Respiratory Cohort
NCT07278700Acute Respiratory Infections, Febrile Illnesses, Community-acquired Pneumonia, Viral Respiratory Tract Infections
Fudan University
Observational
1,000
Shanghai
2025-10-10
Recruiting
Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)
NCT07283575Metastatic Colorectal Cancer ctDNA Surveillance
Fudan University
Observational
497
Shanghai
2025-10-10
Recruiting
A Phase 1 Study of ADI-001 in Rheumatoid Arthritis
NCT07100873Rheumatoid Arthritis (RA)
Adicet Therapeutics
Phase 1
25
Shanghai
2025-10-10
Not yet open
Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker
NCT07120451Advanced Ovarian Cancer
DrugBevacizumab
Fudan University
Phase 2
37
Shanghai
2025-10-10
Not yet open
Evaluating Metabolic Health in People Aged 18 to 60 by Nutrilite Metabolic Health Index
NCT07161557Metabolic Abnormality, Metabolic Disorders
Amway (China) R&D Center
Observational
200
Shanghai
2025-10-09
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of BBM-A101 in the Treatment of Knee Osteoarthritis.
NCT07198555Knee Osteoarthritis
Belief BioMed (Beijing) Co., Ltd
Phase 1
81
Shenzhen, Shanghai
2025-10-09
By invitation
The Effects of a Nurse-led TGA-based Pre-rehabilitation Planning on Perioperative Outcomes in Patients With Liver Cancer: Study and Protocol
NCT07537205Liver Cancer
Fudan University
Not applicable
92
Shanghai
2025-10-08
Recruiting
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
NCT06988488Multiple Myeloma
DrugsMezigdomide·Elranatamab·Dexamethasone
Celgene
Phase 1/2
62
Suzhou, Shanghai
2025-10-07
Recruiting
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
NCT07100106Breast Cancer
DrugsGiredestrant·Abemaciclib
Genentech, Inc.
Phase 1/2
285
Jinan, Shanghai, Tianjin, Nanning
2025-10-07
By invitation
Autologous Islet Transplantation for Diabetes
NCT07118475Diabetes Mellitus, Type 2
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
24
Shanghai
2025-10-07
Recruiting
VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population
NCT07254481Hypertension
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
Phase 1
86
Hangzhou, Shanghai
2025-10-05
Recruiting
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR
NCT07470996Peripheral T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
58
Shanghai
2025-10-01
Recruiting
AN69ST Verse PS in CBP in Septic Children
NCT05692011Sepsis
Children's Hospital of Fudan University
Observational
80
Shanghai
2025-10-01
Recruiting
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL
NCT07185373Primary Central Nervous System Lymphoma
DrugsMTX·Orelabrutinib·Rituximab·Dexamethasone
Huashan Hospital
Phase 2/3
215
Beijing, Chengdu, Fuzhou, Guangzhou, Jinan, Nanchang, Nanjing, Shanghai
2025-10-01
Not yet open
Safety and Effectiveness of the Single-Use Coronary Forward Intravascular Lithotripsy Catheter Combined With the Intravascular Lithotripsy Therapy Device
NCT07109479Coronary Arterial Disease
Spectrumedics Medical Technology(Shanghai)Co.,Ltd
Not applicable
180
Shanghai
2025-10-01
Not yet open
Segmentectomy vs Lobectomy for 2 - 3cm IASLC Grade 1-2 Lung Adenocarcinoma: A Multi-center RCT
NCT07169903Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China
Phase 3
587
Shanghai
2025-10-01
Recruiting
Robustness Evaluation of Deep Inspiration Breath-Hold (DIBH) Plans in Internal Mammary Irradiation
NCT07498855Breast Cancer
Ruijin Hospital
Observational
25
Shanghai
2025-10-01
Active, closed
Clinical Study of Compound Ciwujia Granules in the Treatment of Depression
NCT07085143Depression - Major Depressive Disorder, Depression Disorders
Shanghai Mental Health Center
Phase 4
60
Shanghai
2025-10-01
Not yet open
Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes
NCT07198932Type 2 Diabetes
Yanbing Li
Observational
594
Hangzhou, Baoding, Beijing, Shanghai, Xi'an
2025-10-01
Recruiting
A Study to Evaluate the Effectiveness of Group Gaming Interventions for Individuals With Problematic Gaming Behavior and Gaming Disorder.
NCT07363850Gaming Disorder
Shanghai Mental Health Center
Not applicable
100
Shanghai
2025-10-01
Active, closed
A Novel Strategy for Endoscopic Dual-instrument Retrieval of Upper GI Foreign Body
NCT07649382Foreign Body Ingestion
Shanghai Zhongshan Hospital
Observational
10
Shanghai
2025-10-01
By invitation
Infiltration Pattern of Locally Advanced ESCC
NCT07567716Esophageal Squamous Cell Carcinoma (ESCC), Infiltration, Tumour
Shanghai Chest Hospital
Observational
30
Shanghai
2025-10-01
Not yet open
Development and Validation of an Artificial Intelligence-assisted System for Bowel Cleanliness Assessment Based on Withdrawal Distance Weighting
NCT07150130Colorectal Adenoma
Fudan University
Observational
700
Shanghai
2025-10-01
Recruiting
A Deep Learning Model for Blood Volume Estimation From Multi-modal Ultrasound
NCT06957587Blood Volume Analysis, Ultrasound, Machine Learning
Shanghai 6th People's Hospital
Observational
800
Shanghai
2025-10-01
Recruiting
Close Loop Smart Weaning for INO With PPHN
NCT06832163Persistent Pulmonary Hypertension of the Newborn, Inhaled Nitric Oxide
Children's Hospital of Fudan University
Not applicable
30
Shanghai
2025-10-01
Not yet open
Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer
NCT07134218Rectal Cancer
Changhai Hospital
Phase 2/3
180
Shanghai
2025-10
Not yet open
Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression
NCT07199010Non-small Lung Cancer
DrugTaletrectinib
Innovent Biologics (Suzhou) Co. Ltd.
Observational
50
Shanghai
2025-10
Not yet open
Serplulimab Combined With Cryoablation for Early-Stage Non-Small Cell Lung Cancer
NCT07064876Early Lung Cancer
Xi Junjie
Phase 2
25
Shanghai
2025-10
Not yet open
Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer
NCT07177716Cervical Cancer
DrugsLB4330·LB1410·Lenvatinib
L & L Bio Co., Ltd., Ningbo, China
Phase 2/3
120
Shanghai
2025-10
Not yet open
Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
NCT07156604NSCLC, Neoadjuvant Therapy
DrugVebreltinib Enteric
Fudan University
Phase 2
30
Shanghai
2025-09-30
Not yet open
Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity
NCT07135141Severe Obesity
Beijing Friendship Hospital
Not applicable
256
Beijing, Changsha, Chengdu, Guangzhou, Jinan, Kunming, Nanjing, Shanghai
2025-09-30
Recruiting
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
NCT07130383Advanced Breast Cancer, Advanced Malignant Solid Tumor
DrugsMHB036C·MHB039A
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 2
210
Shanghai
2025-09-30
Not yet open
Dynamic Breath VOC Profiling as a Non-invasive Tool to Assess Hemodialysis Adequacy
NCT07189741Uremia, Uremia; Chronic, Hemodialysis
Second People's Hospital, Shanghai
Observational
50
Shanghai
2025-09-30
Rows per page Showing 1001–1100 of 3827
Previous 9 10 11 12 13 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=11

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.